Aptus Pharma Limited (BOM:544529)
India · Delayed Price · Currency is INR 339.90
+6.65 (2.00%)
At close: Sep 11, 2026
Aptus Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 46.2 | 31 | 7.98 | 1.94 | - |
Depreciation & Amortization | 4.08 | 2.65 | 2.15 | 1.81 | - |
Other Amortization | - | - | - | 0 | - |
Other Operating Activities | 12.31 | 3.7 | 1.95 | 1.26 | - |
Change in Accounts Receivable | -131.21 | -22.86 | -9.56 | -5.49 | - |
Change in Inventory | -65.11 | -36.32 | -11.27 | -9.04 | - |
Change in Accounts Payable | 68.44 | -0.45 | -0.1 | 4.54 | - |
Change in Other Net Operating Assets | 9.25 | 3.9 | -12.89 | 3.17 | - |
Operating Cash Flow | -56.03 | -18.38 | -21.75 | -1.81 | - |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -21.86 | -6.22 | -3.3 | -3.53 | - |
Other Investing Activities | -41.85 | 0.77 | 0.25 | - | - |
Investing Cash Flow | -63.71 | -5.45 | -3.05 | -3.53 | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 63.88 | 11.44 | 0.13 | - |
Long-Term Debt Issued | - | - | 19.52 | 9.4 | - |
Total Debt Issued | - | 63.88 | 30.96 | 9.53 | - |
Short-Term Debt Repaid | -10.76 | - | - | - | - |
Long-Term Debt Repaid | -20.99 | -13.39 | - | - | - |
Total Debt Repaid | -31.75 | -13.39 | - | - | - |
Net Debt Issued (Repaid) | -31.75 | 50.49 | 30.96 | 9.53 | - |
Issuance of Common Stock | 117.6 | 21 | - | - | - |
Other Financing Activities | -7.98 | -4.66 | -2.39 | -1.43 | - |
Financing Cash Flow | 77.87 | 66.83 | 28.57 | 8.1 | - |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - |
Net Cash Flow | -41.87 | 43 | 3.78 | 2.76 | - |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -77.89 | -24.6 | -25.04 | -5.34 | - |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -16.72% | -10.02% | -14.02% | -3.84% | - |
Free Cash Flow Per Share | -5.25 | -2.02 | -6.68 | -2.92 | - |
Levered Free Cash Flow | -92.55 | -32.02 | -18.03 | -6.72 | - |
Unlevered Free Cash Flow | -87.63 | -30.06 | -17.03 | -6.11 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 7.98 | 4.66 | 2.39 | 1.43 | - |
Cash Income Tax Paid | -11.88 | -11.14 | 3.39 | 1.18 | - |
Change in Working Capital | -118.62 | -55.74 | -33.82 | -6.82 | - |